U.S. Senator Marco Rubio (R-FL) joined Senator Cindy Hyde-Smith (R-MS) and U.S. Congressman Bob Latta (R-OH), along with 124 bicameral colleagues, in sending a letter to the U.S. Food and Drug Administration (FDA) requesting the FDA immediately restore more stringent oversight of chemical abortion bills, including the in-person dispensing requirement the FDA suspended in December.